Does Rallies show Form 4 insider transactions for CME?

Yes. Rallies tracks CME insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is CME research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CME. It does not provide personalized investment advice.

CME (CME Group) Stock Analysis - Insider Trades

CME Group (CME) is a publicly traded Financial Services sector company. As of May 20, 2026, CME trades at $291.29 with a market cap of $110.56B and a P/E ratio of 24.74. CME moved -4.05% today. Year to date, CME is +12.12%; over the trailing twelve months it is +8.79%. Its 52-week range spans $213.94 to $329.16. Analyst consensus is neutral with an average price target of $304.20. Rallies surfaces CME's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading CME stock inside the company?

Recent CME insider activity includes DUFFY TERRENCE A sold 26.00K, DUFFY TERRENCE A sold 9.00K, SHEPARD WILLIAM R bought 1.41K, SHEPARD WILLIAM R bought 62.06, and Marcus Jonathan L sold 3.29K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

CME Key Metrics

Key financial metrics for CME
Metric	Value
Price	$291.29
Market Cap	$110.56B
P/E Ratio	24.74
EPS	$11.80
Dividend Yield	1.30%
52-Week High	$329.16
52-Week Low	$213.94
Volume	2.06M
Avg Volume	0
Revenue (TTM)	$6.76B
Net Income	$4.27B
Gross Margin	0.00%

Recent CME Insider Trades

DUFFY TERRENCE A sold 26.00K (~$7.75M) on May 15, 2026.
DUFFY TERRENCE A sold 9.00K (~$2.70M) on May 15, 2026.
SHEPARD WILLIAM R bought 1.41K (~$418.65K) on Mar 26, 2026.
SHEPARD WILLIAM R bought 62.06 (~$18.46K) on Mar 26, 2026.
Marcus Jonathan L sold 3.29K (~$1.03M) on Mar 17, 2026.

Latest CME News

CME Group Flags Hyperliquid’s $21.5B Oil Futures Volume Over KYC-Free Integrity Fears — May 15, 2026
CME Group’s FedWatch Odds at 71% for Hike by March; Presses Hyperliquid Oversight — May 15, 2026
CME Group’s FedWatch Tool Doubles December Hike Odds to 40% — May 15, 2026
CME Group to Launch Market-Cap Weighted Crypto Index Futures with Micro Contracts — May 14, 2026
CME Group Plans GPU-Hour Futures Contract to Benchmark AI Compute — May 12, 2026

CME Analyst Consensus

12 analysts cover CME: 0 strong buy, 4 buy, 5 hold, 3 sell, 0 strong sell. Consensus rating is neutral. Average price target: $304.20.

Common questions about CME

Who is trading CME stock inside the company?: Recent CME insider activity includes DUFFY TERRENCE A sold 26.00K, DUFFY TERRENCE A sold 9.00K, SHEPARD WILLIAM R bought 1.41K, SHEPARD WILLIAM R bought 62.06, and Marcus Jonathan L sold 3.29K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CME?: Yes. Rallies tracks CME insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CME research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CME. It does not provide personalized investment advice.